Prove of Concept Study, to Evaluate the Efficacy, Safety, and Tolerability of IBEROGAST in the Treatment of Bowel Troubles in Patients With Parkinson's Disease
PHASE2CompletedINTERVENTIONAL
Enrollment
45
Participants
Timeline
Start Date
April 30, 2016
Primary Completion Date
April 30, 2018
Study Completion Date
April 30, 2018
Conditions
Gastrointestinal Disorders in Parkinson's Disease
Interventions
DRUG
IBEROGAST
Trial Locations (1)
Unknown
Tiphaine Rouaud, Nantes
All Listed Sponsors
lead
Nantes University Hospital
OTHER
NCT02719496 - Prove of Concept Study, to Evaluate the Efficacy, Safety, and Tolerability of IBEROGAST in the Treatment of Bowel Troubles in Patients With Parkinson's Disease | Biotech Hunter | Biotech Hunter